PreOncology today announced the launch of the nation's first medical-grade, oncologist-led cancer prevention and early detection program, introducing an emerging subspecialty of medical oncology ...
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced a Cooperative ...
MSK created this program because we’re experts in treating this type of cancer. Lobular breast cancer is very different from invasive ductal carcinoma, the most common type of breast cancer. It’s ...
The Ellison Medical Institute (EMI) has entered into an exclusive license with UniQuest, the commercialization company of The ...
We performed a survey of cancer trials published in five journals from January 2018 to May 2024 to assess the trial designs being used in this setting and found that three quarters of them did not ...
The program earned a new accreditation for its work.
Imagine diagnosing cancer, tracking its progress, and identifying treatment resistance—all from a simple blood sample. Just a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results